Published in Biochim Biophys Acta on July 07, 2017
Mutations of the BRAF gene in human cancer. Nature (2002) 65.42
Inflammation and cancer. Nature (2002) 53.78
Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science (2009) 49.82
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science (2002) 49.51
Inflammation and metabolic disorders. Nature (2006) 33.33
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature (1996) 26.30
Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science (1994) 26.02
The metabolic syndrome--a new worldwide definition. Lancet (2005) 23.51
Oxidants, oxidative stress and the biology of ageing. Nature (2000) 23.21
HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science (2001) 22.06
Hypoxia--a key regulatory factor in tumour growth. Nat Rev Cancer (2002) 20.51
C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell (2001) 19.75
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature (2009) 19.56
Alzheimer's disease: genes, proteins, and therapy. Physiol Rev (2001) 19.19
Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science (2004) 17.38
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol (2011) 15.71
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature (2006) 15.69
Regulation of cancer cell metabolism. Nat Rev Cancer (2011) 15.44
Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology (1993) 14.54
Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron (2003) 14.03
Oxidative stress, antioxidants and stress tolerance. Trends Plant Sci (2002) 13.67
Diagnosis of Alzheimer's disease. Arch Neurol (1985) 12.77
Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature (1998) 11.61
TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science (1996) 11.29
Role of autophagy in cancer. Nat Rev Cancer (2007) 10.88
Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes (2008) 10.74
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature (2009) 10.59
ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models. Science (2012) 10.42
AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol (2012) 10.42
Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature (2004) 10.36
High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci (2000) 9.85
Caloric restriction delays disease onset and mortality in rhesus monkeys. Science (2009) 9.84
Neurodegenerative diseases target large-scale human brain networks. Neuron (2009) 9.69
Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol (2009) 9.41
Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature (1995) 9.39
FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell (2007) 8.94
Mammalian SIRT1 represses forkhead transcription factors. Cell (2004) 8.89
mTOR signaling at a glance. J Cell Sci (2009) 8.66
Tau suppression in a neurodegenerative mouse model improves memory function. Science (2005) 8.66
Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med (2003) 8.54
MAP kinase signalling pathways in cancer. Oncogene (2007) 8.52
Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature (2002) 7.88
Ribosomal protein S6 kinase 1 signaling regulates mammalian life span. Science (2009) 7.80
Genetics: influence of TOR kinase on lifespan in C. elegans. Nature (2003) 7.55
A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature (2001) 7.35
Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J (2003) 7.21
A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature (2001) 6.78
Extension of chronological life span in yeast by decreased TOR pathway signaling. Genes Dev (2006) 6.62
The IRF family transcription factors in immunity and oncogenesis. Annu Rev Immunol (2008) 6.60
Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science (2001) 6.17
IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell (2004) 6.13
Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet (2000) 6.12
Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron (2007) 6.07
Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science (2001) 6.00
Foxo3a is essential for maintenance of the hematopoietic stem cell pool. Cell Stem Cell (2007) 5.94
Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med (1998) 5.78
Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med (2010) 5.76
Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci U S A (1997) 5.66
Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat Med (2008) 5.62
Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci (2010) 5.54
Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature (1996) 5.50
Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice. Cell Cycle (2011) 5.42
Unified nomenclature for the winged helix/forkhead transcription factors. Genes Dev (2000) 5.36
Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc Natl Acad Sci U S A (2008) 5.24
Two genetic hits (more or less) to cancer. Nat Rev Cancer (2001) 5.19
Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau. Mol Biol Cell (1992) 5.11
The mighty mouse: genetically engineered mouse models in cancer drug development. Nat Rev Drug Discov (2006) 5.11
Aging, cellular senescence, and cancer. Annu Rev Physiol (2012) 5.08
Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model. Nat Neurosci (2002) 5.01
Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study. Nature (2012) 5.00
Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol (2001) 4.80
Unfolding the role of protein misfolding in neurodegenerative diseases. Nat Rev Neurosci (2003) 4.75
Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease. J Neurosci (2008) 4.63
DAF-16 target genes that control C. elegans life-span and metabolism. Science (2003) 4.57
Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease. Int J Neurosci (1991) 4.53
Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat Rev Cancer (2008) 4.50
Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron (1997) 4.49
Mechanisms of life span extension by rapamycin in the fruit fly Drosophila melanogaster. Cell Metab (2010) 4.44
Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron (2001) 4.42
Mitochondrial abnormalities in Alzheimer's disease. J Neurosci (2001) 4.39
Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation. Nature (2012) 4.37
FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons. J Cell Biol (2003) 4.31
Multiple mutations and cancer. Proc Natl Acad Sci U S A (2003) 4.21
Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat Genet (1997) 4.11
Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat Med (1997) 4.10
The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J Clin Invest (2008) 4.09
Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A (2000) 4.07
Risk of Alzheimer's disease and duration of NSAID use. Neurology (1997) 4.06
The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature (1999) 3.96
Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum Mol Genet (2006) 3.94
Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms. J Neurochem (2003) 3.79
Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J Biol Chem (1998) 3.77
Crosstalk of reactive oxygen species and NF-κB signaling. Cell Res (2010) 3.71
FoxO transcription factors in the maintenance of cellular homeostasis during aging. Curr Opin Cell Biol (2008) 3.70
A comprehensive survey of Ras mutations in cancer. Cancer Res (2012) 3.67
Metabolic adaptations through the PGC-1 alpha and SIRT1 pathways. FEBS Lett (2007) 3.65
Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease. PLoS One (2010) 3.62
LC3 and Autophagy. Methods Mol Biol (2008) 3.59
Redox regulation of PI 3-kinase signalling via inactivation of PTEN. EMBO J (2003) 3.58
pVHL suppresses kinase activity of Akt in a proline-hydroxylation-dependent manner. Science (2016) 1.43
APC(Cdc20) suppresses apoptosis through targeting Bim for ubiquitination and destruction. Dev Cell (2014) 1.09
mTOR signaling in tumorigenesis. Biochim Biophys Acta (2014) 1.06
Functional characterization of Anaphase Promoting Complex/Cyclosome (APC/C) E3 ubiquitin ligases in tumorigenesis. Biochim Biophys Acta (2014) 1.00
Targeting the ubiquitin pathway for cancer treatment. Biochim Biophys Acta (2014) 0.93
Akt-mediated phosphorylation of XLF impairs non-homologous end-joining DNA repair. Mol Cell (2015) 0.88
Smurf1 regulation of DAB2IP controls cell proliferation and migration. Oncotarget (2016) 0.80
K-ras-driven engineered mouse models for pancreatic cancer. Discov Med (2015) 0.78
Inhibition of Rb Phosphorylation Leads to mTORC2-Mediated Activation of Akt. Mol Cell (2016) 0.77
The SCFβ-TRCP E3 ubiquitin ligase complex targets Lipin1 for ubiquitination and degradation to promote hepatic lipogenesis. Sci Signal (2017) 0.75
Functional characterization of AMP-activated protein kinase signaling in tumorigenesis. Biochim Biophys Acta (2016) 0.75
Cullin 3SPOP ubiquitin E3 ligase promotes the poly-ubiquitination and degradation of HDAC6. Oncotarget (2017) 0.75